Virtus ETF Advisers’s Cascadian Therapeutics, Inc. CASC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2016
Q2
Sell
-19,445
Closed -$148K 158
2016
Q1
$148K Sell
19,445
-1,209
-6% -$9.2K 0.2% 123
2015
Q4
$275K Buy
+20,654
New +$275K 0.75% 47